The marathon is still on to discover the root cause of Alzheimer’s disease in order to develop an effective treatment option or cure, and the latest research may have brought us closer to that goal. Scientists are intrigued by a particular non-amyloid-beta protein, KCNB1, which builds up and oxidizes in the brains of those experiencing the effects of Alzheimer‘s, leading to the production of amyloid-beta.
The study, led by Federico Sesti, professor of neuroscience and cell biology at Rutgers Robert Wood Johnson Medical School, showed that KCNB1 levels in both mice and humans with Alzheimer’s as well as those with traumatic brain injury, were much higher than those in normal brains.
To counteract the effects of elevated KCNB1, the drug Sprycel (currently approved as a treatment for leukemia) was tested in mice, and showed great promise. Sesti shares, “Our study shows that this drug and similar ones could potentially be used to treat Alzheimer’s, a discovery that leads the way to launching a clinical trial to test this drug in humans.”
As we await further advances in this latest development in Alzheimer’s research, we at Atlanta Home Care Partners continue to provide the highly specialized, compassionate and skilled dementia home care that those with Alzheimer’s disease and dementia need to achieve the highest possible quality of life. Contact us online or call us at (404) 228-0103 to request a free in-home consultation to learn more about how our dementia home care providers can ensure that your senior loved one is living life to the fullest, while allowing you the peace of mind in knowing you can take much-needed breaks from care.